Open AccessDoes restricting fluid volume impact post-ERCP pancreatitis in patient with heart disease?
Author(s) -
Ko Tomishima,
Shōzō Ishii,
Toshio Fujisawa,
Noboru Yatagai,
Daishi Kabemura,
Shusei Sato,
Nozomi Amano,
Akira Murata,
Hironori Tsuzura,
Shunsuke Sato,
Kouhei Matsumoto,
Yuji Shimada,
Takuya Genda,
Akihito Nagahara,
Hiroyuki Isayama
Publication year - 2021
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/sjg.sjg_693_20
Subject(s) - medicine , pericardial fluid , pancreatitis , body mass index , major duodenal papilla , gastroenterology , acute pancreatitis , incidence (geometry) , heart failure , heart disease , cardiology , surgery , pericardium , physics , optics
Two hundred and forty seven of 480 patients with naïve papilla undergoing therapeutic ERCP between April 2013 and March 2018 were enrolled for the study. The following patient characteristics were investigated: age, sex, body mass index, previous diseases (heart disease, renal failure, cerebrovascular disorders, coexisting malignancy and pulmonary disease), history of PEP, common bile duct diameter, diverticula and volume of fluid infused 24 hours after the procedure. All ERCP cases had naïve papilla and had undergone treatment.